LAPUROON Aurora Super and Vivid: Where the Names Stop Being a Ladder

Two boxes sit next to each other on the same shelf, both labelled LAPUROON Aurora. One says Super and declares PDRN at 2 percent. The other says Vivid and declares it at 0.2 percent. A buyer reading only those two numbers concludes that Super is the stronger product and moves on. That conclusion survives exactly until you multiply the percentages by the volumes, at which point the second active in both boxes points the other way.

What each Aurora box actually declares

Start with the declared figures, because everything that follows is arithmetic on them rather than interpretation. Aurora Super is supplied as two pre-filled syringes of 2.5mL, declaring PDRN at 2 percent and hyaluronic acid at 1 percent. Aurora Vivid is supplied as five vials of 5mL, declaring PDRN at 0.2 percent and hyaluronic acid at 1 percent. Both list further components: peptides, amino acids, vitamins and minerals in each, with retinol named in both and glutathione and ascorbic acid named additionally in Vivid.

The hyaluronic acid figure is the one most readers skip, and it is the reason this comparison is not a straight line. Both products declare it at the same 1 percent. That looks like a point of equivalence, and at the level of concentration it is. At the level of what is in the box it is not, because the two boxes hold very different volumes.

The declared percentages are also worth taking literally as what they are, which is a mass fraction. Two percent in a 2.5mL syringe is 50mg. Point two percent in a 5mL vial is 10mg. Neither number is printed on the carton, but both follow from figures that are, and a buyer who does the multiplication is not adding information, only reading what was already declared.

The supporting lists diverge as well, and they diverge in a way that is easy to miss because both cartons use similar language. Super names peptides, amino acids, vitamins and minerals, with retinol among them. Vivid names a multi-peptide complex, amino acids, vitamins and minerals, with retinol, and adds glutathione and ascorbic acid. Two products in one range, sharing a brand and a hyaluronic acid figure, are not carrying the same set of components.

That difference matters for a reason unrelated to which formulation anyone prefers. It means the two boxes are not one product at two strengths. A range built as a ladder would hold the composition constant and move a single number. This range moves the composition too, which is why treating Vivid as a diluted Super produces a description that is wrong in both directions at once.

What makes this pair worth an article is that the arithmetic does not produce a single ranking. It produces three, and they disagree.

Ten times, five times, twice, and then the other direction

Read the PDRN line alone and the gap between the two products shrinks as you move down the table. At the concentration level Super carries ten times as much. Per container that becomes five times, because a Vivid vial holds twice the volume of a Super syringe. Per box it becomes twice, because there are five Vivid vials against two Super syringes. Three true statements, three different multiples, one pair of products.

Then the hyaluronic acid line reverses the direction entirely. Both declare 1 percent, so per box the totals are 50mg for Super and 250mg for Vivid. The box with a tenth of the PDRN concentration carries five times the hyaluronic acid. Anyone who bought Super believing it to be the more concentrated product in every respect bought the more concentrated product in one respect and the less loaded one in another.

None of this is a defect in the products or a fault in the labelling. Both declare their figures plainly, and both figures are true. The difficulty is that a percentage answers a question about a millilitre while a purchase is a question about a box, and the two questions have different answers whenever the presentations differ. That is the general form of the problem, and it recurs across the category. We set out the unit half of it in reading an injectable label. Aurora is the cleanest example of the comparative half.

It is worth being explicit about which of the three readings is usually the right one, because the answer depends on the question rather than on the products. A buyer costing a purchase is asking about the box, so the per-box figure is the relevant one. A buyer planning inventory across a period is asking about containers, since a container is the unit that gets opened. A buyer comparing this range against a different maker's product is usually asking about concentration, because that is the figure both cartons state in the same terms. The three readings are not competing answers to one question. They are answers to three questions that get asked in the same conversation.

The trap is switching basis mid-comparison without noticing. Reading Super's 2 percent against Vivid's per-box volume, or Vivid's five vials against Super's concentration, produces a ratio that describes nothing. That is not a hypothetical error. It is what happens whenever a spreadsheet has one column for percent and another for pack size and the person reading it forms an impression from whichever column is wider.

The practical consequence for a buyer is that a comparison sheet with one column headed PDRN percent is not a comparison sheet. It is one of at least three, and which one matters depends on what is being compared: cost per box, material per container, or concentration at the point of use.

Does a higher tier name mean more active?

Super and Vivid read like rungs on a ladder. Most product ranges in this category are built that way, with names that ascend, and buyers have been trained by the rest of the market to treat the fancier word as the fuller product. Aurora does not follow that pattern, and it is worth being precise about why.

Neither word encodes a quantity. Super does not mean twice, or ten times, or per box. Vivid does not mean larger. They are line designations, the same class of naming we found across the filler catalogue where products identify themselves as Fine, Deep or Sub-Q without stating a volume. A designation tells you the maker considers these products distinct. It does not tell you the axis along which they are distinct, and in this case that axis turns out to be two axes running opposite ways.

There is also a format difference doing quiet work. Super is a pre-filled syringe and Vivid is a vial. Those are different objects with different handling consequences, and neither name mentions it. A buyer who ordered on the name alone and expected a syringe would find five vials in the box, which is not a substitution or an error but a fact that lived only in the specification.

The reading habit that survives this is simple. Treat the tier word as a pointer to a spec sheet rather than as information in itself, and let the declared figures do the ranking. This is the same discipline that applies when a brand name spans more than one licensed product, which is what we found when reading the three Korean filings that share the Hyaron name.

Where PDRN percentage sits among the other PDRN questions

Concentration is the most visible PDRN specification and it is not the only one that varies. Molecular weight distribution, source species and purification method all differ between products, and none of them appears as a percentage on a carton. A product declaring 2 percent has told you the mass fraction and nothing about chain length, which we treat separately in reading a PDRN skin booster.

The Korean register adds a further layer. PDRN appears there under a specific ingredient name with a specific count of licences, and products marketed as PDRN boosters are not all filed the same way. Which register a product sits in changes which fields exist to be checked, and we set out what the drug register does and does not hold for this ingredient in what the Korean register licenses PDRN as. A buyer comparing Aurora Super against a product from a different maker is often comparing across that boundary without noticing.

Both Aurora products also carry a list beyond the two headline actives, and those lists are not identical. Vivid names glutathione and ascorbic acid where Super does not. Whether that matters depends entirely on what a buyer is sourcing for, but it is another respect in which the two boxes are not the same product at two strengths. They are two formulations that share a brand and a hyaluronic acid concentration.

For the wider map of which actives define which part of this category, the skin booster family by active sets out the divisions that hold across makers rather than within one range.

Verifying an Aurora box against its own declared numbers

This pair is unusually easy to verify because the product declares enough for the box to check itself. Every figure on the carton is connected to another figure by arithmetic, and a counterfeit or a mislabelled unit has to keep all of them consistent rather than just one.

Begin with the internal check. Concentration, volume and container count are three declared values, and the fourth value, total material, is fixed by the other three. A carton claiming 2 percent in a 5mL container is describing a different product from a carton claiming 2 percent in 2.5mL, even if the front panel reads identically. Where a supplier quotes only a percentage, the missing volume is not a detail they omitted for brevity. It is the value that makes the percentage mean anything.

Then check the presentation against the name in the specification rather than against expectation. Aurora Super is declared as pre-filled syringes and Aurora Vivid as vials, so a box of Super containing vials has failed before any question about contents arises. Format mismatch is the cheapest verification signal in this category because it requires no equipment and survives every language barrier, a point that applies equally to the pre-filled presentations we discussed when reading the Hyaron name across three Korean filings.

Ask the supplier which of the two products they are quoting, by full name, and treat a reply of just LAPUROON Aurora as an unanswered question. This is the same failure mode that appears whenever a brand spans more than one product: the brand narrows the field without identifying the item, and a quote that stops at the brand has left the buyer to guess between two formulations that differ on volume, presentation, PDRN concentration and supporting composition.

Finally, ask for the documentation that sits behind the carton rather than the carton alone. Import records and batch identifiers are ordinary requests, and a supplier working through official channels produces them without friction.

Reading a two-product range before you order

The routine here generalises to any range where the presentations differ, and it takes about a minute.

Write down concentration and volume for each product before comparing anything. If either is missing from the supplier's material, that is the first question to ask, and a supplier who can only supply a tier name has not answered it. Then multiply to get material per container and per box, and notice whether the ranking changes as you go. If it does, decide which basis your decision actually rests on before you let a number persuade you.

Check every declared active, not only the headline one. The Aurora pair is instructive precisely because the second active reverses the first. A range where one component ascends and another descends is not unusual once you look, but it is invisible if you compare on a single line.

Confirm the presentation separately from the name. Syringe against vial changes what arrives in the box, and it is declared in the specification rather than in the tier word. Format is also the field that a mismatched shipment fails first, which makes it useful as a verification step as well as a purchasing one.

Finally, keep the arithmetic with the order record. A note reading "Super, 2 percent, 2.5mL, two syringes, 100mg PDRN per box" is durable and checkable six months later. A note reading "Super, the stronger one" is neither.

Sourcing LAPUROON Aurora, and what to confirm

KSTATION stocks both LAPUROON AURORA Super and LAPUROON AURORA Vivid as separate listings, with the concentration, volume and container count stated on each rather than left to the tier name. That separation is deliberate. When two products in a range differ on more than one axis, presenting them as a single item with a variant selector hides exactly the information a buyer needs to compare them.

On arrival, three checks close the loop. Confirm the container type matches the listing, since syringe against vial is the fastest mismatch to spot. Confirm the vial or syringe count, because the per-box arithmetic depends on it entirely. Confirm that the declared percentages on the carton match what was ordered, as those are the figures every downstream calculation rests on.

For buyers working across the PDRN end of the range, other products declaring PDRN as a primary active sit under skin boosters and ampoules, including KIARA REJU, which states its own concentration and volume in the same explicit way. Comparing those two ranges is a reasonable exercise as long as the basis is fixed first.

One further note on the pair specifically. Because Super and Vivid differ on presentation as well as concentration, they are not interchangeable in an order even when the total PDRN happens to work out close. Substituting one for the other changes the container type, the container count and the hyaluronic acid load in the same move, and a substitution described as an equivalent is describing only one of those three. If a supplier proposes one in place of the other, the useful reply is to ask which basis they are calling equivalent.

Our shipping arrangements for this category, including the duties-paid option available on United States orders, are set out on the shipping options page.

Sources and references

• Manufacturer-declared specifications for LAPUROON AURORA Super (2.5mL x 2 syringes) and LAPUROON AURORA Vivid (5mL x 5 vials), as supplied to KSTATION, read 3 September 2026. Per-container and per-box figures in this article are arithmetic on those declared values.
• KSTATION editorial policy, on how declared specifications are separated from claims in our writing.